483
Navinta, LLCNavinta, LLC – FDA 483, Mar 28, 2019
Record Details
An FDA inspection of Navinta, LLC's corporate headquarters in Ewing, NJ, revealed a significant documentation deficiency in their postmarketing safety reporting. The firm repeatedly failed to include copies of published scientific articles when submitting 15-day Alert reports based on scientific literature. This indicates a lapse in regulatory submission completeness.
View Company Profile
ID · 220bccf8-f824-45eb-9607-8652af691d90
Other documents for Navinta, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.